Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenograftsWilliam D. Gwynne(University of Toronto), John A. Hassell(McMaster University)OncotargetMarch 29, 201710.18632/oncotarget.16646Cited by 52SaveCiteExport RISWatch citationsRelated PapersSmall Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer|PLoS ONE|2012|93Antagonists of the serotonin receptor 5A target human breast tumor initiating cells|BMC Cancer|2020|20